DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo


2.57 0.08 (3.21%)

REAL-TIME: Last trade at

Extended Hours: $2.57 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

VVUS $2.57 3.21%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.51
Previous Close $2.49
Daily Range $2.50 - $2.61
52-Week Range $2.41 - $6.28
Market Cap $267.0M
P/E Ratio -3.11
Dividend (Yield) $0.00 (0.0%)
Volume 1,859,292
Average Daily Volume 2,959,979
Current FY EPS -$1.30




Drug Makers

VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary Rss Feed

Biotech Stocks: 2 to Avoid, 1 to Buy

Motley Fool contributor Todd Campbell offers insight on three biotech stocks, including two that investors should stay away from.

Has Orexigen Delivered A Death Knell To Vivus?

Orexigen: Contrave Gathering Momentum

Vivus, Arena, Or Orexigen - Which Will Win The Anti-Obesity Market Share Race?

Orexigen - Contrave Scripts Up, Equity Down, Approval In Europe Still Not Announced

Ferrellgas, Prothena Lead Friday's After-Hours Movers

Arena: Belviq Scripts See Modest Rise, Revenue Story Not Promising

Vivus' Qsymia Breaks 3-Week Stagnancy, Could Start Upward Trend

Orexigen - Contrave Scripts Rise Over 6%, But The Focus Is On Europe

Too Good to Be True? Proceed With Caution on These 2 Biotechs

All that glitters is not gold, and sometimes a much-hyped biotech isn’t quite as sparkly once you scratch the surface.

See More VVUS News...

VVUS's Top Competitors

VVUS $2.57 (3.21%)
Current stock: VVUS
JNJ $100.34 (0.20%)
Current stock: JNJ
PFE $34.53 (1.08%)
Current stock: PFE
NVS $100.40 (0.84%)
Current stock: NVS